We are live on ! Find out more
TC

Tavio Capital Portfolio holdings

AUM $75.4M
1-Year Est. Return 27.99%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
10 Year Est. Return
AUM
$183M
AUM Growth
-$62.5M
Cap. Flow
-$73.9M
Cap. Flow %
-40.31%
Top 10 Hldgs %
100%
Holding
13
New
3
Increased
1
Reduced
3
Closed
5

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COR icon
1
Cencora
COR
$59.9B
$35.3M 19.27%
+384,697
New +$31.8M
ELV icon
2
Elevance Health
ELV
$80.9B
$30.3M 16.52%
134,554
-128,610
-49% -$27.4M
UHS icon
3
Universal Health Services
UHS
$9.15B
$26.9M 14.66%
236,979
+32,282
+16% +$3.45M
MOH icon
4
Molina Healthcare
MOH
$11.7B
$25.4M 13.84%
330,747
-206,445
-38% -$14.9M
CVS icon
5
CVS Health
CVS
$137B
$24.5M 13.35%
+337,537
New +$24.5M
BSX icon
6
Boston Scientific
BSX
$65.4B
$19.7M 10.74%
793,865
-900,501
-53% -$24.8M
DVA icon
7
DaVita
DVA
$15.2B
$15.1M 8.24%
+209,130
New +$12.9M
TVTX icon
8
Travere Therapeutics
TVTX
$5.27B
$6.19M 3.38%
293,923
CNC icon
9
Centene
CNC
$32.8B
-593,462
Closed -$28.7M
MCK icon
10
McKesson
MCK
$98.5B
-140,372
Closed -$21.6M
SPY icon
11
State Street SPDR S&P 500 ETF Trust
SPY
$774B
-55,000
Closed -$13.8M
TDOC icon
12
Teladoc Health
TDOC
$1.7B
-160,011
Closed -$5.3M
XBI icon
13
State Street SPDR S&P Biotech ETF
XBI
$10.4B
-115,821
Closed -$10M

Similar funds

Tavio Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Tavio Capital held 13 positions worth $183M, down 25% from $246M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tavio Capital withdrew a net $73.9M in Q4 2017, closing 5 positions and reducing 3 holdings. Its most notable exit was Centene, an estimated $28.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 90% a quarter earlier.

Against the trend, Tavio Capital opened a new position in Cencora worth $35.3M.

  • Tavio Capital's largest Q4 2017 buy was Cencora: 384,697 shares worth $35.3M.
  • Tavio Capital added most to Universal Health Services in Q4 2017, an estimated $3.45M increase.
  • Tavio Capital's biggest Q4 2017 reduction was Elevance Health, cutting an estimated $27.4M.
  • Tavio Capital fully exited Centene in Q4 2017, selling an estimated $28.7M.
  • Tavio Capital's ten largest holdings make up 100% of its $183M portfolio in Q4 2017.
  • Tavio Capital opened 3 new positions and closed 5 in Q4 2017.
  • Tavio Capital's portfolio value fell 25% quarter-over-quarter to $183M.

Based on Tavio Capital's 13F filing for Q4 2017, filed 12 Feb 2018.